The Zacks Analyst Blog Highlights:Walt Disney, Chevron, Wal-Mart Stores, Pfizer and Microsoft - KMPH FOX 26 | Central San Joaquin Valley News Source

The Zacks Analyst Blog Highlights:Walt Disney, Chevron, Wal-Mart Stores, Pfizer and Microsoft

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Zacks Investment Research, Inc.

CHICAGO, Feb. 10, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Walt Disney Company (NYSE:DIS-Free Report), Chevron Corp. (NYSE:CVX-Free Report), Wal-Mart Stores Inc. (NYSE:WMT-Free Report), Pfizer Inc. (NYSE:PFE-Free Report) and Microsoft Corp. (Nasdaq:MSFT-Free Report).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Friday's Analyst Blog:

Dow 30 Stock Roundup: Disney Stars, Chevron Tanks

The Dow navigated troubled waters this week, encountering its worst decline on Monday since June last year. The blue chip index made crucial gains on Thursday, buoyed by job market numbers and encouraging earnings from Disney. However, it is still down 0.5% this week.

Last Week's and Month's Performance

On Friday, market sentiment turned bearish following dismal results and forecasts, and another drop in Euro-zone inflation. This was also the benchmarks' first monthly decline since last August.

Through January, emerging market concerns, China's dismal economic data and finally the Fed taper dealt severe blows to the market. In January, the blue-chip index plunged 5.3%. This was the Dow's worst start to a year since 2009.

The Dow This Week

Till now, the Dow has continued to suffer hard times, but for Thursday's events. Weaker-than-expected domestic manufacturing data delivered a crushing blow to the blue chip index on Monday, which declined 2.1%. For the first time since Dec 28, 2012, the Dow closed below its 200-day moving average.

Tuesday, was decidedly better with the blue chip index gaining 0.5% on the back of encouraging corporate numbers. Encouraging service sector data failed to add enough strength to the Dow on Wednesday, which slipped by 0.03%.

A drop in initial claims and encouraging results from an entertainment giant helped benchmarks achieve their best single-day performance since December 18. The gains somewhat offset weekly losses and Friday's session will be crucial to help the Dow post weekly gains, which gained 1.2% over the trading day.

Components Which Moved the Index

The Walt Disney Company (NYSE:DIS-Free Report) enjoyed a 3.4% increase on the index after the media giant posted outstanding first-quarter fiscal 2014 results this Thursday. The company's adjusted earnings came in at $1.04 per share, surging 32% year over year. Results were propelled by double-digit revenue growth across Studio Entertainment, Consumer Products as well as Interactive businesses.

Chevron Corp. (NYSE:CVX-Free Report) reported weak fourth quarter results on falling production and refinery margins. It reflected in its share price on the NYSE, where it fell almost 4% in early trade last Friday. Earnings per share (excluding adjustments for foreign-currency effects) came in at $2.47 and deteriorated considerably from the year-ago adjusted profit of $3.78 per share.

Wal-Mart Stores Inc. (NYSE:WMT-Free Report) said it expects its earnings to be at or slightly below the low end of its previous forecast of $1.60 to $1.70 per share. For fiscal 2014, Walmart expects its earnings to be at or slightly below the low end of its previous forecast of $5.11 to $5.21 per share. The restructuring of Sam's Club unit in the United States, food safety allegations, and weakness in the emerging markets, are responsible for the company's weaker outlook.

Pfizer Inc. (NYSE:PFE-Free Report) gained significantly following positive top-line data from a phase II study (PALOMA-1 or study 1003) on its oncology candidate palbociclib. Shares of the company were up by as much as 4% on the news during early trading on Monday. Pfizer was the sole stock to gain among the Dow 30 companies on the day.

Microsoft Corp. (Nasdaq:MSFT-Free Report) named Satya Nadella as their new CEO, after a long search process that began last August. Nadella's division raked in over $20 billion in revenues and over $8 billion in operating income last fiscal year. The firm's Azure service has grown rapidly under his stewardship, giving the company a new growth avenue.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on DIS - FREE

Get the full Report on CVX - FREE

Get the full Report on WMT - FREE

Get the full Report on PFE - FREE

Get the full Report on MSFT - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KMPH. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.